QP Forum 2011
Over the past few years the role and duties of the Qualified Person keep increasing in significance and scope. Being the key person in the quality function of a pharmaceutical company, the QP has to consider many issues to fulfil the responsibilities and to comply with European legislation.
Budapest, Hungary, 12 December 2011
Over the past few years the role and duties of the Qualified Person keep increasing in significance and scope. Being the key person in the quality function of a pharmaceutical company, the QP has to consider many issues to fulfil the responsibilities and to comply with European legislation.
To help European QPs to stay on top of current developments as well as to enable them to network and exchange personal experience and information, the European QP Association specifically developed the QP Forum. This Forum has become the meeting place for QPs and aspiring QPs from Europe and beyond. The annual meeting also addresses upper management functions and authority representatives, though, who want to be informed about the latest development regarding the duties and responsibilities of Qualified Persons.
Like every year, representatives from authorities as well as QPs and well-known experts will present latest issues and share their point of view during this year’s Forum scheduled in Budapest, Hungary, from 1-2 December. During the two pre-conference sessions on 30 November and the six parallel sessions as part of the Forum, various case studies will be presented and discussed to come up with possible solutions.
Contact details
To find out more, please contact
European QP Association
info@qp-association.eu
www.qp-forum.org
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
